Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 7 (11) , 1051-1061
- https://doi.org/10.3109/02713688809001875
Abstract
Subcutaneous immunization with purified HSV-1 glycoprotein D (gD) protects susceptible A/J mice against keratitis and encephalitis following corneal HSV-1 challenge. Mice were immunized with gD, in complete Freund's adjuvant, 3.0 micrograms/mouse followed by two booster doses of 1.5 micrograms/mouse at weeks 2 and 4. Control groups of A/J mice were injected with either complete Freund's adjuvant (unimmunized controls) or live HSV-1 MP strain (immunized controls). All mice were challenged ocularly at week 5 with HSV-1, F strain (6.5 × 103 PFU) after corneal scarification. None of the 16 animals immunized with gD developed stromal keratitis; only 3 out of 12 animals immunized with live HSV-1 developed a stromal keratitis; 13 out of 16 CFA primed unimmunized mice developed severe stromal keratitis within 14 days post corneal challenge, and 3 out of 16 control CFA primed animals died within 16 days post corneal challenge. At the time of sacrifice (3 weeks post corneal challenge), the ipsilateral trigeminal ganglia were removed and assayed for latent HSV-1 using cocultivation on Vero cell monolayers. The results of these experiments indicate that immunization with gD produces protection against latent ganglionic infection in 56% of the immunized animals, and provides protection against keratitis and death following HSV corneal challenge.This publication has 22 references indexed in Scilit:
- Immunomodulation of experimental murine herpes simplex keratitis: I. UV–HSV protectionCurrent Eye Research, 1988
- Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infectionClinical Immunology and Immunopathology, 1986
- Genetic studies on murine susceptibility to herpes simplex keratitisClinical Immunology and Immunopathology, 1986
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985
- Dissemination of Herpes Simplex Virus in Nude Mice after Intracutaneous Inoculation and Effect of Antibody on the Course of InfectionJournal of General Virology, 1982
- Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.British Journal of Ophthalmology, 1981
- Effect of Immune Serum on the Establishment of Herpes Simplex Virus Infection in Trigeminal Ganglia of Hairless MiceJournal of General Virology, 1980
- Host-cell Response to Herpes Virus Infection in Central and Peripheral Nervous Tissue in VitroJournal of General Virology, 1979
- Activation of latent herpesvirus hominis in explants of rabbit trigeminal ganglia: the influence of immune serumArchiv für die gesamte Virusforschung, 1977
- Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virusNature, 1976